???global.info.a_carregar???
I have started my research career studying transthyretin amyloidosis, developing new anti-TTR monoclonal antibodies and exploring their use in the diagnosis and therapy of the disease. Based on this early work, anti-TTR immunosorbents were used the 90s in a pilot trial of immunoapheresis for the treatment of the disease in 6 patients [Costa & Costa. Amyloid 1998;5:143-4]. I maintain an active interest in the study of the molecular pathology of amyloidosis [Beirão et al. Clin Nephrol. 2010;74:327-35; Moreira et al. Amyloid 2015;22:93-9]. In the last decade, my main interests were the study of epilepsy and autoimmune diseases, with a focus on genetic determinants of susceptibility, disease course and presentation, and their interaction with environmental factors [Bettencourt et al. J Immunol Res. 2015;2015:948723; Bettencourt et al. J Steroid Biochem Mol Biol. 2017 Sep 22. pii: S0960-0760(17)30264-9]. With the acquisition of in-house NGS capability, my main focus is now the exploration of the role of the microbiome in autoimmune disease.
Identificação

Identificação pessoal

Nome completo
Paulo Manuel de Castro Pinho e Costa
Data de nascimento
1958/01/16
Género
Masculino

Nomes de citação

  • Costa, Paulo P
  • Costa, Paulo MP

Identificadores de autor

Ciência ID
6A17-F7BE-D4BC
ORCID iD
0000-0001-6125-7000
Researcher Id
B-4392-2008
Scopus Author Id
14023271500

Endereços de correio eletrónico

  • paulo.costa@insa.min-saude.pt (Profissional)

Telefones

Telefone
  • (+351) 22 340 110 Ext.: 2180 (Profissional)

Moradas

  • INSA Dr. Ricardo Jorge. Rua Alexandre Herculano 321, 4000-053, Porto, Porto, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica - Imunologia
  • Ciências Médicas e da Saúde - Medicina Básica - Patologia
  • Ciências Médicas e da Saúde - Medicina Básica - Neurociências
  • Ciências Médicas e da Saúde - Medicina Básica - Genética Humana
Formação
Grau Classificação
1995
Concluído
Ciências Biomédicas (Doutoramento)
Especialização em Outra:Patologia
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Amiloidoses Transtirretemicas da Biopatologia À Terapêutica" (TESE/DISSERTAÇÃO)
1986 - 1991
Concluído
Especialista em Anatomia Patológica (Especialização pós-licenciatura)
Ordem dos Médicos, Portugal
1982
Concluído
Medicina (Licenciatura)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"-" (TESE/DISSERTAÇÃO)
13
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento
Empregador
2002 - Atual Investigador principal (carreira) (Investigação) Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
1997 - 2002 Investigador Auxiliar (carreira) (Investigação) Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento
Empregador
2023 - Atual Professor Associado Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
1997 - 2023 Professor Auxiliar Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Projetos

Projeto

Designação Financiadores
2009 - 2011 The relevance of HHV-6B in patients with Mesial Temporal Lobe Epilepsy(MTLE) due to Hippocampal Sclerosis (HS): implications in prevention and treatment
PIC/IC/83297/2007
Investigador
Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
1997 - 2000 Desenvolvimento de imunoadsorventes de uso médico, de custo reduzido, com base em mini-anticorpos recombinantes de cadeia única
PRAXIS/PCNA/C/BIO/50/96
Investigador responsável
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Fundação para a Ciência e a Tecnologia
Produções

Publicações

Artigo em revista
  1. João Chaves; Bárbara Leal; Ana Sardoeira; Vanessa Carvalho; Raquel Samões; Joel Freitas; Rui Chorão; et al. "Different relationships between epilepsy syndromes and autoimmune diseases". Epileptic Disorders 25 1 (2023): 33-44. http://dx.doi.org/10.1002/epd2.20048.
    10.1002/epd2.20048
  2. Ricardo Martins-Ferreira; Bárbara Leal; João Chaves; Laura Ciudad; Raquel Samões; António Martins da Silva; Paulo Pinho Costa; Esteban Ballestar. "Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy". Clinical Epigenetics 14 1 (2022): http://dx.doi.org/10.1186/s13148-022-01416-2.
    10.1186/s13148-022-01416-2
  3. Ricardo Martins-Ferreira; Bárbara Leal; João Chaves; Tianlu Li; Laura Ciudad; Rui Rangel; Agostinho Santos; et al. "Epilepsy progression is associated with cumulative DNA methylation changes in inflammatory genes". Progress in Neurobiology 209 (2022): 102207-102207. https://doi.org/10.1016/j.pneurobio.2021.102207.
    10.1016/j.pneurobio.2021.102207
  4. Leal, BG; Barros Barbosa, A; Ferreirinha, F; Chaves, J; Rangel, R; Santos, A; Carvalho, C; et al. "Mesial Temporal Lobe Epilepsy (MTLE) Drug-Refractoriness Is Associated With P2X7 Receptors Overexpression in the Human Hippocampus and Temporal Neocortex and May Be Predicted by Low Circulating Levels of miR-22". FRONTIERS IN CELLULAR NEUROSCIENCE (2022):
    10.3389/fncel.2022.910662
  5. Ferreira, A.M.; Leal, B.; Ferreira, I.; Brás, S.; Moreira, I.; Samões, R.; Sousa, A.P.; et al. "Depression and anxiety in multiple sclerosis patients: The role of genetic variability of interleukin 1ß". Multiple Sclerosis and Related Disorders 52 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85105808028&partnerID=MN8TOARS.
    10.1016/j.msard.2021.102982
  6. Leal, B.; Carvalho, C.; Ferreira, A.M.; Nogueira, M.; Brás, S.; Silva, B.M.; Selores, M.; Costa, P.P.; Torres, T.. "Serum Levels of miR-146a in Patients with Psoriasis". Molecular Diagnosis and Therapy 25 4 (2021): 475-485. http://www.scopus.com/inward/record.url?eid=2-s2.0-85105395705&partnerID=MN8TOARS.
    10.1007/s40291-021-00531-9
  7. Martins-Ferreira R; Leal B; Costa PP; Ballestar E. "Microglial innate memory and epigenetic reprogramming in neurological disorders.". Progress in neurobiology (2020): http://europepmc.org/abstract/med/33309803.
    10.1016/j.pneurobio.2020.101971
  8. Chaves J; Martins-Ferreira R; Ferreira AM; Brás S; Carvalho C; Bettencourt A; Samões R; et al. "Immunogenetic protective factors in Genetic Generalized Epilepsy.". Epilepsy research (2020): http://europepmc.org/abstract/med/32585211.
    10.1016/j.eplepsyres.2020.106396
  9. Martins-Ferreira, R.; Chaves, J.; Carvalho, C.; Bettencourt, A.; Chorão, R.; Freitas, J.; Samões, R.; et al. "Circulating microRNAs as potential biomarkers for genetic generalized epilepsies: a three microRNA panel". European Journal of Neurology 27 4 (2020): 660-666. http://dx.doi.org/10.1111/ene.14129.
    Publicado • 10.1111/ene.14129
  10. Nuno Gomes; André Cerejeira; Elisabete Moreira; Catarina Costa; Paulo Pinho e Costa; Filomena Azevedo. "Rhinophyma or something more?". International Journal of Dermatology (2020): https://doi.org/10.1111/ijd.14825.
    10.1111/ijd.14825
  11. Chaves, João; Martins-Ferreira, Ricardo; Carvalho, Cláudia; Bettencourt, Andreia; Brás, Sandra; Chorão, Rui; Freitas, Joel; et al. "Apolipoprotein E isoforms and susceptibility to genetic generalized epilepsies". International Journal of Neuroscience (2020): 1-6. http://dx.doi.org/10.1080/00207454.2019.1709840.
    Publicado • 10.1080/00207454.2019.1709840
  12. Martins E; Urbano J; Leite S; Pinto A; Garcia R; Bergantim R; Rodrigues-Pereira P; et al. "Cardiac Amyloidosis Associated with Apolipoprotein A-IV Deposition Diagnosed by Mass Spectrometry-Based Proteomic Analysis.". European journal of case reports in internal medicine (2019): http://europepmc.org/abstract/med/31893197.
    10.12890/2019_001237
  13. Santos, Ernestina; Bettencourt, Andreia; Duarte, Sara; Gabriel, Denis; Oliveira, Vanessa; da Silva, Ana Martins; Costa, Paulo Pinho; et al. "Refractory myasthenia gravis: Characteristics of a portuguese cohort". Muscle & Nerve 60 2 (2019): 188-191. http://dx.doi.org/10.1002/mus.26507.
    Publicado • 10.1002/mus.26507
  14. Tavares, Isabel; Oliveira, Márcia E.; Maia, Nuno; Moreira, Luciana; Castro Lacerda, Pedro; Santos, Josefina; Santos, Rosário; Pinho Costa, Paulo; Lobato, Luísa. "Haplotype analysis of newly diagnosed Portuguese and Brazilian families with fibrinogen amyloidosis caused by the FGA p.Glu545Val variant". Amyloid 26 sup1 (2019): 144-145. http://dx.doi.org/10.1080/13506129.2019.1582500.
    Publicado • 10.1080/13506129.2019.1582500
  15. Tavares, Isabel; Silvano, José; Moreira, Luciana; Oliveira, Márcia E.; Silva, Roberto; Sampaio, Susana; Costa, Paulo Pinho; Lobato, Luísa. "Short-term complications after renal transplantation in AFibE526V (p.Glu545Val) amyloidosis". Amyloid 26 sup1 (2019): 162-163. http://dx.doi.org/10.1080/13506129.2019.1583196.
    Publicado • 10.1080/13506129.2019.1583196
  16. Costa, Paulo. "Estrogen Metabolism-Associated CYP2D6 and IL6-174G/C Polymorphisms in Schistosoma haematobium Infection". International Journal of Molecular Sciences (2017): http://www.mdpi.com/1422-0067/18/12/2560.
    10.3390/ijms18122560
  17. Leal B; Chaves J; Carvalho C; Rangel R; Santos A; Bettencourt A; Lopes J; et al. "Brain expression of inflammatory mediators in Mesial Temporal Lobe Epilepsy patients.". Journal of neuroimmunology (2017): http://europepmc.org/abstract/med/29153613.
    10.1016/j.jneuroim.2017.10.014
  18. Bárbara Leal; João Chaves; Cláudia Carvalho; Andreia Bettencourt; Joel Freitas; João Lopes; João Ramalheira; et al. "Age of onset of mesial temporal lobe epilepsy with hippocampal sclerosis: the effect of apolipoprotein E and febrile seizures". International Journal of Neuroscience 127 9 (2017): 800-804. https://doi.org/10.1080%2F00207454.2016.1264396.
    10.1080/00207454.2016.1264396
  19. Costa, Paulo. "Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the north of Portugal.". The Journal of steroid biochemistry and molecular biology (2017): http://europepmc.org/abstract/med/28951256.
    10.1016/j.jsbmb.2017.09.016
  20. Costa, Paulo. "The vitamin D receptor gene FokI polymorphism and Multiple Sclerosis in a Northern Portuguese population.". Journal of neuroimmunology (2017): http://europepmc.org/abstract/med/28601283.
    10.1016/j.jneuroim.2017.05.005
  21. Costa, Paulo. "Unrecognized Fibrinogen A a-Chain Amyloidosis: Results From Targeted Genetic Testing.". American journal of kidney diseases : the official journal of the National Kidney Foundation (2017): http://europepmc.org/abstract/med/28359658.
    10.1053/j.ajkd.2017.01.048
  22. Costa, Paulo. "HLA and age of onset in myasthenia gravis.". Neuromuscular disorders : NMD (2017): http://europepmc.org/abstract/med/28495048.
    10.1016/j.nmd.2017.04.002
  23. Costa, Paulo. "Immunogenetic Predisposing Factors for Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.". The International journal of neuroscience (2017): http://europepmc.org/abstract/med/28675059.
    10.1080/00207454.2017.1349122
  24. Costa, Paulo. "Fibrinogen A alpha-chain amyloidosis: a non-negligible cause of chronic kidney disease in dialysis patients.". Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2017): http://europepmc.org/abstract/med/28434302.
    10.1080/13506129.2017.1281119
  25. Costa, Paulo. "Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohort.". Immunologic research (2017): http://europepmc.org/abstract/med/27423437.
    10.1007/s12026-016-8829-3
  26. Costa, Paulo. "Serum 25-hydroxyvitamin D levels in a healthy population from the North of Portugal.". The Journal of steroid biochemistry and molecular biology (2016): http://europepmc.org/abstract/med/27825978.
    10.1016/j.jsbmb.2016.11.005
  27. Torres, T.; Bettencourt, N.; Ferreira, J.; Carvalho, C.; Mendonça, D.; Pinho-Costa, P.; Vasconcelos, C.; Selores, M.; Silva, B.. "Influence of TNF-a gene polymorphisms in coronary artery calcification in psoriasis patients". Journal of the European Academy of Dermatology and Venereology 30 1 (2016): 191-193. http://www.scopus.com/inward/record.url?eid=2-s2.0-84954531180&partnerID=MN8TOARS.
    10.1111/jdv.12706
  28. Neves F; Abrantes J; Almeida T; de Matos AL; Costa PP; Esteves PJ. "Genetic characterization of interleukins (IL-1a, IL-1ß, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs.". (2015): http://europepmc.org/abstract/med/26395994.
    10.1177/1753425915606209
  29. Lacerda PC; Moreira L; Vitorino R; Costa PP. "Use of MALDI-TOF Mass Spectrometry to Assay the Transthyretin V30M Mutation in Serum From a Liver Transplant Donor: A Case Report.". (2015): http://europepmc.org/abstract/med/25943235.
    10.1097/TP.0000000000000658
  30. Carvalho C; Marinho A; Leal B; Bettencourt A; Boleixa D; Almeida I; Farinha F; et al. "Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients.". (2015): http://europepmc.org/abstract/med/25661837.
  31. Torres T; Bettencourt N; Ferreira J; Carvalho C; Mendonça D; Pinho-Costa P; Vasconcelos C; Selores M; Silva B. "Influence of interleukin-6 gene polymorphisms in epicardial adipose tissue and coronary artery calcification in patients with psoriasis.". (2015): http://europepmc.org/abstract/med/25040543.
    10.1111/bjd.13271
  32. Bettencourt A; Carvalho C; Leal B; Brás S; Lopes D; Martins da Silva A; Santos E; et al. "The Protective Role of HLA-DRB1(*)13 in Autoimmune Diseases.". (2015): http://europepmc.org/abstract/med/26605347.
    10.1155/2015/948723
  33. Neves F; Abrantes J; Almeida T; Costa PP; Esteves PJ. "Evolutionary Insights into IL17A in Lagomorphs.". (2015): http://europepmc.org/abstract/med/26788019.
    10.1155/2015/367670
  34. Domingos J; Ferrão C; Ramalho J; Rodrigues T; Moreira B; Santos E; Bettencourt A; et al. "Characteristics of Neuro-Behcet's Disease in a Case-Series from a Single Centre in Northern Portugal.". (2015): http://europepmc.org/abstract/med/25997636.
    10.1159/000381210
  35. Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P. "Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.". (2015): http://europepmc.org/abstract/med/26096568.
    10.3109/13506129.2015.1015678
  36. Moreira L; Beirão JM; Beirão I; Pinho e Costa P. "Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B.". (2015): http://europepmc.org/abstract/med/26088020.
    10.3109/13506129.2015.1007497
  37. Carvalho, C.; Marinho, A.; Leal, B.; Bettencourt, A.; Boleixa, D.; Almeida, I.; Farinha, F.; et al. "Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients". Lupus 24 8 (2015): 846-853. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930886919&partnerID=MN8TOARS.
    10.1177/0961203314566636
  38. Silva, L.; Lopes, J.; Ramalheira, J.; Cunha, D.; Carvalho, C.; Bettencourt, A.; Brás, S.; et al. "Obstructive sleep apnoea syndrome and HLA in the North of Portugal,Síndrome de apnea obstructiva del sueño y HLA en el norte de Portugal". Revista de Neurologia 61 7 (2015): 301-307. http://www.scopus.com/inward/record.url?eid=2-s2.0-84942897710&partnerID=MN8TOARS.
    10.33588/rn.6107.2015199
  39. Beirão JM; Malheiro J; Lemos C; Matos E; Beirão I; Pinho-Costa P; Torres P. "Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis.". (2014): http://europepmc.org/abstract/med/25475560.
    10.3109/13506129.2014.989318
  40. Neves F; Abrantes J; Pinheiro A; Almeida T; Costa PP; Esteves PJ. "Convergent evolution of IL-6 in two leporids (Oryctolagus and Pentalagus) originated an extended protein.". (2014): http://europepmc.org/abstract/med/25027474.
    10.1007/s00251-014-0787-0
  41. Torres T; Bettencourt N; Ferreira J; Carvalho C; Mendonça D; Pinho-Costa P; Vasconcelos C; Selores M; Silva B. "Influence of TNF-a gene polymorphisms in coronary artery calcification in psoriasis patients.". (2014): http://europepmc.org/abstract/med/25174782.
  42. Bettencourt A; Silva AM; Carvalho C; Leal B; Santos E; Costa PP; Silva BM. "The role of KIR2DS1 in multiple sclerosis--KIR in Portuguese MS patients.". (2014): http://europepmc.org/abstract/med/24529855.
    10.1016/j.jneuroim.2014.01.009
  43. Martins-da-Silva A; Lopes J; Ramalheira J; Carvalho C; Cunha D; Costa PP; Silva MB. "Usefulness of genetic characterization of narcolepsy and hypersomnia on phenotype definition: a study in Portuguese patients.". (2014): http://europepmc.org/abstract/med/24399620.
    10.33588/rn.5802.2013361
  44. Bettencourt A; Leal B; Carvalho C; Oliveira R; Martins Silva A; Vaz Patto J; Bastos M; et al. "CC chemokine receptor polymorphism CCR5¿32 in Portuguese Behcet's disease patients.". (2014): http://europepmc.org/abstract/med/25268662.
  45. Carvalho, C.; Calvisi, S.L.; Leal, B.; Bettencourt, A.; Marinho, A.; Almeida, I.; Farinha, F.; et al. "CCR5-Delta32: implications in SLE development". International journal of immunogenetics 41 3 (2014): 236-241. http://www.scopus.com/inward/record.url?eid=2-s2.0-85027939983&partnerID=MN8TOARS.
    10.1111/iji.12094
  46. Beirão JM; Moreira LM; Oliveira JC; Menéres MJ; Pessoa BB; Matos ME; Costa PP; Torres PA; Beirão IB. "Aqueous humor erythropoietin levels in open-angle glaucoma patients with and without TTR V30M familial amyloid polyneuropathy.". (2014): http://europepmc.org/abstract/med/25018619.
  47. Beirão, N.M.; Miranda, V.; Beirão, I.; Costa, P.P.; Torres, P.. "The use of intravitreal ranibizumab to treat neovascular glaucoma because of retinal amyloid angiopathy in familial amyloidosis transthyretin v30m related". Retinal Cases and Brief Reports 7 1 (2013): 114-116. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878093576&partnerID=MN8TOARS.
    10.1097/ICB.0b013e3182681259
  48. Kasperaviciute, D.; Catarino, C.B.; Matarin, M.; Leu, C.; Novy, J.; Tostevin, A.; Leal, B.; et al. "Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A". Brain 136 10 (2013): 3140-3150. http://www.scopus.com/inward/record.url?eid=2-s2.0-84884838178&partnerID=MN8TOARS.
    10.1093/brain/awt233
  49. Beirão, J.M.; Matos, M.E.; Beirão, I.B.; Costa, P.P.; Torres, P.A.; Beirão, João M.; Matos, Maria E.; et al. "Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M)". European Journal of Ophthalmology 23 2 (2013): 156-163. http://www.scopus.com/inward/record.url?eid=2-s2.0-84874171172&partnerID=MN8TOARS.
    Publicado • 10.5301/ejo.5000197
  50. Beirão M; Matos E; Beirão I; Pinho-Costa P; Torres P. "No ocular involvement in familial amyloidotic polyneuropathy ATTR V30M domino liver recipients.". (2012): http://europepmc.org/abstract/med/22443165.
    10.1111/j.1432-2277.2012.01467.x
  51. Bettencourt A; Martins da Silva A; Pinho E Costa P; Martins Silva B. "Molecular genetic studies of multiple sclerosis in the portuguese population.". (2012): http://europepmc.org/abstract/med/23079250.
  52. Bettencourt, A.; Martins Da Silva, A.; Pinho E Costa, P.; Martins Silva, B.. "Molecular genetic studies of multiple sclerosis in the Portuguese population | Estudos genéticos em doentes Portugueses com esclerose múltipla". Acta Medica Portuguesa 25 4 (2012): 224-230. http://www.scopus.com/inward/record.url?eid=2-s2.0-84867909675&partnerID=MN8TOARS.
  53. Beirão, N.M.; Matos, M.E.; Meneres, M.J.; Beirão, I.M.; Costa, P.P.; Torres, P.A.. "Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients". Amyloid 19 3 (2012): 146-151. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865218034&partnerID=MN8TOARS.
    10.3109/13506129.2012.710669
  54. Beirão, J.M.; Moreira, L.V.; Lacerda, P.C.; Vitorino, R.P.; Beirão, I.B.; Torres, P.A.; Costa, P.P.. "Inability of mutant transthyretin V30M to cross the blood-eye barrier". Transplantation 94 8 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84868139951&partnerID=MN8TOARS.
    10.1097/TP.0b013e318269e6d1
  55. Beirão, M.; Matos, E.; Reis, R.; Beirão, I.; Costa, P.P.; Torres, P.. "Spatial visual contrast sensitivity in liver transplanted Portuguese familial amyloidotic polyneuropathy (ATTR V30M) patients". Amyloid 19 3 (2012): 152-155. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865205684&partnerID=MN8TOARS.
    10.3109/13506129.2012.712075
  56. Beirão, M.; Matos, E.; Beirâo, I.; Costa, P.P.E.; Torres, P.. "Anticipation of presbyopia in Portuguese familial amyloidosis ATTR V30M". Amyloid 18 3 (2011): 92-97. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052190905&partnerID=MN8TOARS.
    10.3109/13506129.2011.576719
  57. Tavares, I.; Lobato, L.; Moreira, L.; Santos, J.; Lacerda, P.; Pinheiro, J.; Costa, P.. "Long-term follow-up of patients with hereditary fibrinogen A alpha-chain amyloidosis.". Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 18 Suppl 1 (2011): 216-217. http://www.scopus.com/inward/record.url?eid=2-s2.0-82255165417&partnerID=MN8TOARS.
    10.3109/13506129.2011.627069
  58. Beirão, N.M.; Matos, E.; Beirão, I.; Costa, P.P.; Torres, P.. "Recurrence of vitreous amyloidosis and need of surgical reintervention in portuguese patients with familial amyloidosis ATTR V30M". Retina 31 7 (2011): 1373-1377. http://www.scopus.com/inward/record.url?eid=2-s2.0-79961208874&partnerID=MN8TOARS.
    10.1097/IAE.0b013e318203c0c2
  59. Duarte, R.; Carvalho, C.; Pereira, C.; Bettencourt, A.; Carvalho, A.; Villar, M.; Domingos, A.; et al. "HLA class II alleles as markers of tuberculosis susceptibility and resistance | O papel do HLA classe II na susceptibilidade/resistência à tuberculose". Revista Portuguesa de Pneumologia 17 1 (2011): 15-19. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955665023&partnerID=MN8TOARS.
    10.1016/S0873-2159(11)70005-8
  60. Bettencourt, A.; Silva, A.M.; Santos, E.; Gomes, S.; Mendonça, D.; Costa, P.P.; Faustino, P.; Silva, B.M.. "HFE gene polymorphisms and severity in Portuguese patients with multiple sclerosis". European Journal of Neurology 18 4 (2011): 663-666. http://www.scopus.com/inward/record.url?eid=2-s2.0-79952725496&partnerID=MN8TOARS.
    10.1111/j.1468-1331.2010.03109.x
  61. Duarte, R.; Carvalho, C.; Pereira, C.; Bettencourt, A.; Carvalho, A.; Villar, M.; Domingos, A.; et al. "HLA class II alleles as markers of tuberculosis susceptibility and resistance,O papel do HLA classe II na susceptibilidade/resistência À tuberculose". Revista Portuguesa de Pneumologia (English Edition) 17 1 (2011): 15-19. http://www.scopus.com/inward/record.url?eid=2-s2.0-85038619284&partnerID=MN8TOARS.
    10.1016/S2173-5115(11)70005-7
  62. Tavares, I.; Lobato, L.; Moreira, L.; Santos, J.; Lacerda, P.; Pinheiro, J.; Costa, P.. "Long-term follow-up of patients with hereditary fibrinogen A alpha-chain amyloidosis". Amyloid 18 SUPPL. 1 (2011): 221-222. http://www.scopus.com/inward/record.url?eid=2-s2.0-79960023250&partnerID=MN8TOARS.
    10.3109/13506129.2011.574354
  63. Beirão, I.; Moreira, L.; Barandela, T.; Lobato, L.; Silva, P.; Gouveia, C.M.; Carneiro, F.; et al. "Erythropoietin production by distal nephron in normal and familial amyloidotic adult human kidneys". Clinical Nephrology 74 5 (2010): 327-335. http://www.scopus.com/inward/record.url?eid=2-s2.0-78649902510&partnerID=MN8TOARS.
  64. Silva, A.M.; Bettencourt, A.; Pereira, C.; Santos, E.; Carvalho, C.; Mendonça, D.; Costa, P.P.; Monteiro, L.; Martins, B.. "Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis". Multiple Sclerosis 15 6 (2009): 771-774. http://www.scopus.com/inward/record.url?eid=2-s2.0-66249137162&partnerID=MN8TOARS.
    10.1177/1352458509104588
  65. Bettencourt, A.; Pereira, C.; Carvalho, L.; Carvalho, C.; Patto, J.V.; Bastos, M.; Silva, A.M.; et al. "New insights of HLA class I association to Behçet's disease in Portuguese patients". Tissue Antigens 72 4 (2008): 379-382. http://www.scopus.com/inward/record.url?eid=2-s2.0-51649106008&partnerID=MN8TOARS.
    10.1111/j.1399-0039.2008.01087.x
  66. Beirão, I.; Moreira, L.; Porto, G.; Lobato, L.; Fonseca, I.; Cabrita, A.; Costa, P.M.P.. "Low erythropoietin production in familial amyloidosis TTR V30M is not related with renal congophilic amyloid deposition: A clinicopathologic study of twelve cases". Nephron - Clinical Practice 109 2 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-48249126810&partnerID=MN8TOARS.
    10.1159/000142527
  67. Beirão, I.; Almeida, S.; Swinkels, D.; Costa, P.M.P.; Moreira, L.; Fonseca, I.; Freitas, C.; Cabrita, A.; Porto, G.. "Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M". Blood Cells, Molecules, and Diseases 41 2 (2008): 175-178. http://www.scopus.com/inward/record.url?eid=2-s2.0-48749088914&partnerID=MN8TOARS.
    10.1016/j.bcmd.2008.04.008
  68. Beirão, I.; Lobato, L.; Costa, P.M.P.; Fonseca, I.; Silva, M.; Bravo, F.; Cabrita, A.; Porto, G.. "Liver transplantation and anemia in familial amyloidosis ATTR V30M". Amyloid 14 1 (2007): 33-37. http://www.scopus.com/inward/record.url?eid=2-s2.0-33947645336&partnerID=MN8TOARS.
    10.1080/13506120601116476
  69. Silva, A.M.; Pereira, C.; Bettencourt, A.; Carvalho, C.; Couto, A.R.; Leite, M.I.; Marta, M.; et al. "The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population". Journal of the Neurological Sciences 258 1-2 (2007): 69-74. http://www.scopus.com/inward/record.url?eid=2-s2.0-34249880485&partnerID=MN8TOARS.
    10.1016/j.jns.2007.02.033
  70. Pinho e Costa, P.. "A brief history of the Portuguese Amyloid Research Centre | Breve história do Centro de Estudos de Paramiloidose". Sinapse 6 1 SUPPL. 1 (2006): 180-183. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745375045&partnerID=MN8TOARS.
  71. Costa, P.P.. "The molecular diagnosis in familial amyloidotic polyneuropathy | Diagnóstico molecular da polineuropatia amiloidótica familiar". Sinapse 6 1 SUPPL. 1 (2006): 138-142. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745431694&partnerID=MN8TOARS.
  72. Almeida, V.M.; Costa, P.M.; Moreira, P.; Gonçalves, J.; Braga, J.; Costa, Paulo P. "Birth of two healthy females after preimplantation genetic diagnosis for familial amyloid polyneuropathy". Reproductive BioMedicine Online 10 5 (2005): 641-644. http://www.scopus.com/inward/record.url?eid=2-s2.0-18444397475&partnerID=MN8TOARS.
    10.1016/s1472-6483(10)61672-0
  73. Moura, E.; Pinho Costa, P.M.; Moura, D.; Guimarães, S.; Vieira-Coelho, M.A.. "Decreased tyrosine hydroxylase activity in the adrenals of spontaneously hypertensive rats". Life Sciences 76 25 (2005): 2953-2964. http://www.scopus.com/inward/record.url?eid=2-s2.0-16844380955&partnerID=MN8TOARS.
    10.1016/j.lfs.2004.11.017
  74. Beirão, I.; Lobato, L.; Costa, P.M.; Fonseca, I.; Mendes, P.; Silva, M.; Bravo, F.; et al. "Kidney and anemia in familial amyloidosis type I.". Kidney international 66 5 (2004): 2004-2009. http://www.scopus.com/inward/record.url?eid=2-s2.0-21644479059&partnerID=MN8TOARS.
    10.1111/j.1523-1755.2004.00971.x
  75. Silva, B.M.; Thorlacius, T.; Benediktsson, K.; Pereira, C.; Fossdal, R.; Jonsson, H.H.; Silva, A.; et al. "A whole genome association study in multiple sclerosis patients from north Portugal". Journal of Neuroimmunology 143 1-2 (2003): 116-119. http://www.scopus.com/inward/record.url?eid=2-s2.0-10744219785&partnerID=MN8TOARS.
    10.1016/j.jneuroim.2003.08.024
  76. Fiszman, M.L.; Di Egidio, M.; Ricart, K.C.; Repetto, M.G.; Borodinsky, L.N.; Llesuy, S.F.; Saizar, R.D.; et al. "Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1". Archives of Neurology 60 4 (2003): 593-597. http://www.scopus.com/inward/record.url?eid=2-s2.0-0344406277&partnerID=MN8TOARS.
    10.1001/archneur.60.4.593
  77. Pereira, C; Pinto, D; Pereira, O; Farinha, F; Massa, A; Cerqueira, J; Pauperio, S; et al. "Psoriasis and psoriatic arthritis: A possible modifying influence of a non-HLA gene in an HLA class I associated disease". European Journal of Immunogenetics (2001):
  78. Adams, D.; Samuel, D.; Goulon-Goeau, C.; Nakazato, M.; Costa, P.M.P.; Feray, C.; Planté, V.; et al. "The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation". Brain 123 7 (2000): 1495-1504. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033919415&partnerID=MN8TOARS.
    10.1093/brain/123.7.1495
  79. Beirão, I.; Lobato, L.; Riedstra, S.; Costa, P.M.P.; Pimentel, S.; Guimarães, S.; Costa, Paulo P. "Ineffectiveness of dialysis in transthyretin (TTR) clearance in Familial Amyloid Polyneuropathy type I, in spite of lower stability of the TTR Met30 variant". Clinical Nephrology 51 1 (1999): 45-49. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032924669&partnerID=MN8TOARS.
  80. Costa, Paulo P; Beirão, I.; Lobato, L.; Guimarães, S.M.; Cardoso, P.; Costa, P.M.P.; Coelho, T.; Rocha, G.; Guimarães, S.. "Early destructive spondyloarthropathy from combined beta2-microglobulin and transthyretin Met30 amyloidosis in a dialysed patient.". Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 13 12 (1998): 3223-3225. http://europepmc.org/abstract/med/9870498.
    10.1093/ndt/13.12.3223
  81. Costa PM; Costa PP. "The future of selective apheresis in FAP.". (1998): http://europepmc.org/abstract/med/9686308.
    10.3109/13506129808995291
  82. Costa, Paulo P; Riedstra, S.; Ferreira, J.P.M.; Costa, P.M.P.. "Study of an anti-human transthyretin immunoadsorbent. Influence of coupling chemistry on binding capacity and ligand leakage.". Journal of chromatography. B, Biomedical sciences and applications 705 2 (1998): 213-222. http://europepmc.org/abstract/med/9521557.
    10.1016/S0378-4347(97)00546-X
  83. Ando, Y.; Anan, I.; Suhr, O.; Holmgren, G.; Costa, P.M.P.; Costa, Paulo P. "Detection of a variant protein in hair: New diagnostic method in Portuguese type familial amyloid polyneuropathy". British Medical Journal 316 7143 (1998): 1500-1501. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032537367&partnerID=MN8TOARS.
    10.1136/bmj.316.7143.1500
  84. Vallar, L.; Costa, P.M.P.; Teixeira, A.; Pfister, M.; Barrois, R.; Costa, P.P.; Rivat, C.. "Immunoadsorption procedure as a potential method for the specific ß2-microglobulin removal from plasma of patients with chronic renal failure". Journal of Chromatography B: Biomedical Applications 664 1 (1995): 97-106. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028890103&partnerID=MN8TOARS.
    10.1016/0378-4347(94)00402-Q
  85. Costa, Paulo P; Holmgren, G.; Costa, P.M.P.; Andersson, C.; Asplund, K.; Steen, L.; Beckman, L.; et al. "Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate.". Journal of medical genetics 31 5 (1994): 351-354. http://europepmc.org/abstract/med/8064809.
    10.1136/jmg.31.5.351
  86. López Andreu FR; Munar-Qués M; Parrilla P; Escribano Soriano JB; Costa PP; Costa PM; Almeida MR; et al. "[Liver transplantation for the treatment of type I familial amyloidotic polyneuropathy]". (1993): http://europepmc.org/abstract/med/8255113.
  87. Costa PM; Teixeira A; Saraiva MJ; Costa PP. "Immunoassay for transthyretin variants associated with amyloid neuropathy.". (1993): http://europepmc.org/abstract/med/8394031.
    10.1111/j.1365-3083.1993.tb01710.x
  88. Saraiva MJ; Almeida Mdo R; Sherman W; Gawinowicz M; Costa P; Costa PP; Goodman DS. "A new transthyretin mutation associated with amyloid cardiomyopathy.". (1992): http://europepmc.org/abstract/med/1570831.
  89. Regnault V; Costa PM; Teixeira A; Rivat C; Stoltz JF; Saraiva MJ; Costa PP. "Specific removal of transthyretin from plasma of patients with familial amyloidotic polyneuropathy: optimization of an immunoadsorption procedure.". (1992): http://europepmc.org/abstract/med/1316882.
    10.1177/039139889201500411
  90. Costa PP; Jacobsson B; Collins VP; Biberfeld P. "Unmasking antigen determinants in amyloid.". (1986): http://europepmc.org/abstract/med/2431032.
    10.1177/34.12.2431032
Capítulo de livro
  1. Leal, Bárbara; Costa, Paulo P; Martins da Silva, Berta. "Genétca". In Epilepsia. Conceitos, Diagnóstico e Tratamento, editado por Pimentel, José; Bentes, Carla, 53-72. Lisboa, Portugal: Lidel - Edições Técnicas, Lda., 2016.
    Publicado
Livro
  1. Vasconcelos, C.; Carvalho, C.; Leal, B.; Pereira, C.; Bettencourt, A.; Costa, P.P.; Marinho, A.; et al. HLA in Portuguese systemic lupus erythematosus patients and their relation to clinical features. 2009.
    10.1111/j.1749-6632.2009.04873.x
Pré-impressão
  1. Esteban Ballestar; Ricardo Martins-Ferreira; Josep Calafell-Segura; Bárbara Leal; Javier Rodríguez-Ubreva; Elisabetta Mereu; Paulo Pinho e Costa. "The Human Microglia Atlas (HuMicA) Unravels Changes in Homeostatic and Disease-Associated Microglia Subsets across Neurodegenerative Conditions". 2023. https://doi.org/10.21203/rs.3.rs-3227213/v1.
    10.21203/rs.3.rs-3227213/v1
Resumo em conferência
  1. Carvalho, C; Leal, B; Bettencourt, A; Costa, A; Bras, S; Ramalheira, JEDP; Lopes, JMCF; et al. "Killer cell immunoglobulin-like receptor genes and sleep disorders in a Portuguese population". 2019.
  2. Leal, B; Bettencourt, A; Ferreira, AM; Carvalho, C; Moreira, I; Costa, PP; Da Silva, BM; Cavaco, S; Da Silva, AM. "IL1B rs16944 and depression symptoms in multiple sclerosis patients". 2017.
  3. Leal, B; Carvalho, C; Chaves, J; Bettencourt, A; Ferreira, R; Rangel, R; Santos, A; et al. "Inverse correlation between miR-22 serum levels and p2x7r-mediated inflammatory response in mesial temporal lobe epilepsy patients". 2017.
    10.1016/j.jns.2017.08.295
  4. Bettencourt, A; Leal, B; Ferreira, M; Carvalho, C; Moreira, I; Santos, E; Costa, PP; et al. "Depression symptoms in multiple sclerosis patients - The role of IL1B". 2017.
    10.1016/j.jns.2017.08.691
  5. Bettencourt, A; Boleixa, D; Sousa, AL; Santos, E; Marinho, A; Oliveira, JC; Reis, J; et al. "Vitamin D levels and severity in multiple sclerosis patients from the North of Portugal". 2016.
  6. Boleixa, D; Goncalves, A; Bettencourt, A; Leal, B; Carvalho, C; Bras, S; Mendes, A; et al. "Genetic variation in DRD3 and impulse control disorders in Parkinson's disease". 2015.
  7. Leal, B; Carvalho, C; Chaves, JMM; Bettencourt, A; Freitas, J; Lopes, JMCF; Ramalheira, JEDP; et al. "Expression of miR146-a, an inflammation-associated microRNA, in mesial temporal lobe epilepsy". 2015.
  8. Bettencourt, A; Silva, AM; Carvalho, C; Leal, B; Santos, E; Samoes, R; Costa, PP; Silva, BM. "Vitamin D status and vitamin D receptor gene Fok1 and Taq1 polymorphisms in Portuguese patients with multiple sclerosis". 2014.
  9. Leal, B; Chaves, J; Barreira, AC; Carvalho, C; Bettencourt, A; Lopes, J; Ramalheira, J; et al. "Is serotonin transporter implicated in mesial temporal lobe epilepsy development?". 2014.
  10. Chaves, J; Leal, B; Barreira, A; Carvalho, C; Bettencourt, A; Lopes, J; Ramalheira, J; et al. "SEROTONIN RECEPTORS IN MESIAL TEMPORAL LOBE EPILEPSY". 2014.
  11. Leal, B; Zenatti, L; Rangel, R; Chaves, J; Carvalho, C; Bettencourt, A; Santos, A; et al. "ADENOSINERGIC SYSTEM IN MESIAL TEMPORAL LOBE EPILEPSY". 2014.
  12. Ferreira, JCP; Torres, T; Carvalho, CA; Bettencourt, A; Leal, B; Vasconcelos, C; Costa, PP; Selores, M; Silva, BM. "Apoe isoforms in patients with psoriasis". 2013.
  13. Ferreira, JP; Torres, T; Carvalho, C; Bettencourt, A; Leal, B; Vasconcelos, C; Costa, PP; Selores, M; Silva, BM. "IL-6 and TNF-alpha polymorphisms in portuguese psoriatic patients". 2013.
  14. Martins da Silva, AM; Leal, B; Chaves, J; Carvalho, C; Bettencourt, A; Branco, RC; Ferreira, J; Costa, PP; Martins da Silva, BM. "APOE ISOFORMS IN FOCAL EPILEPSIES: AN ASSOCIATION STUDY IN A PORTUGUESE POPULATION". 2013.
  15. Chaves, J; Leal, B; Carvalho, C; Bettencourt, A; Bras, S; Barreira, A; Boleixa, D; et al. "MESIAL TEMPORAL LOBE EPILEPSY AND SEROTONIN: THE ROLE OF HTR2A RECEPTOR". 2013.
  16. Leal, B; Castelo Branco, RC; Rangel, R; Chaves, J; Carvalho, C; Bettencourt, A; Honavar, M; et al. "HUMAN HERPES VIRUS 6B AND MESIAL TEMPORAL LOBE EPILEPSY WITH HIPPOCAMPAL SCLEROSIS (MTLE-HS): IS THERE A LINK?". 2013.
  17. Neves, F; Abrantes, J; Costa, PP; Esteves, PJ. "Comparative evolutionary analysis of IL6 in lagomorphs". 2013.
  18. Lopes, A; Fonseca, M; Almeida, I; Perneta, F; Bettencourt, A; Carvalho, C; Marinho, A; et al. "HLA-DRB1 ALLELES AND AUTOANTIBODY PRODUCTION IN A PORTUGUESE SCLERODERMA COHORT". 2012.
  19. Bettencourt, A; Carvalho, C; Leal, B; Maia, S; Lopes, D; Fonseca, M; Almeida, I; et al. "ASSOCIATION OF HLA-DRB1 ALLELES AND AUTOANTIBODY PRODUCTION IN A PORTUGUESE SCLERODERMA COHORT". 2012.
  20. Carvalho, C; Bettencourt, A; Leal, B; Fonseca, M; Lopes, D; Perneta, F; Pestana, J; et al. "STUDY OF KIR GENES IN PORTUGUESE PATIENTS WITH SYSTEMIC SCLEROSIS". 2012.
  21. Martins Da Silva, AM; Branco, R; Leal, B; Rangel, R; Carvalho, C; Bettencourt, A; Chaves, J; et al. "ARE GLUTAMINE SINTHETASE EXPRESSION LEVELS ASSOCIATED WITH MESIAL TEMPORAL LOBE EPILEPSY WITH HIPPOCAMPAL SCLEROSIS?". 2012.
  22. Leal, B; Branco, R; Rangel, R; Bettencourt, A; Carvalho, C; Chaves, J; Santos, A; et al. "EXCITATORY AMINO ACID TRANSPORTER-1 EXPRESSION IN HUMAN MESIAL TEMPORAL LOBE EPILEPSY WITH HIPPOCAMPAL SCLEROSIS". 2012.
  23. Chaves, J; Brito, C; Leal, B; Carvalho, C; Bettencourt, A; Branco, R; Martins Da Silva, AM; Costa, PP; Martins Da Silva, BM. "INFLAMMATORY PROCESS AND MESIAL TEMPORAL LOBE EPILEPSY WITH EPILEPSY: THE ROLE OF IL-1 beta". 2012.
  24. Bettencourt, A; Silva, AM; Carvalho, C; Leal, B; Santos, E; Coutinho, E; Costa, PP; Silva, BM. "Fok1 vitamin D receptor gene polymorphism is associated with multiple sclerosis in a Portuguese population". 2011.
  25. Silva, AM; Bettencourt, A; Ribeiro, A; Goncalves, A; Pinto, C; Moreira, I; Santos, E; et al. "Dementia in multiple sclerosis: demographic, clinical and genetic features". 2011.
  26. Bettencourt, A; Silva, AM; Carvalho, C; Leal, B; Santos, E; Coutinho, E; Pinho e Costa, PPE; Silva, BM. "Vitamin D receptor gene Fok1 polymorphism in Portuguese patients with multiple sclerosis". 2011.
  27. Martins Silva, AM; Bettencourt, A; Goncalves, A; Pinto, C; Santos, E; Moreira, I; Tavares, A; et al. "Does APOE-epsilon4 have a detrimental effect in multiple sclerosis?". 2011.
  28. Branco, RC; Leal, B; Rangel, R; Chaves, J; Bettencourt, A; Carvalho, C; Lima, JL; et al. "EXPRESSION OF GLUTAMATE TRANSPORTERS IN HUMAN MESIAL TEMPORAL LOBE EPILEPSY WITH HIPOCAMPPAL SCLEROSIS: A PRELIMINARY STUDY". 2011.
  29. Leal, B; Carvalho, C; Bettencourt, A; Carneiro, P; Cerveira, C; Vasconcelos, C; Barbosa, P; Costa, PP; Silva, BM. "Killer immunoglobulin-like receptor genes and rheumatoid arthritis in a Portuguese population". 2011.
  30. Leal, B; Rangel, R; Carvalho, C; Moreira, L; Chaves, J; Silva, AM; Lima, JL; et al. "INFLAMMATION IN HUMAN MESIAL TEMPORAL LOBE EPILEPSY WITH HIPPOCAMPAL SCLEROSIS: PRELIMINARY EVALUATION". 2010.
  31. Carvalho, C; Lopes, D; Bettencourt, A; Leal, B; Maia, S; Vita, P; Almeida, F; et al. "Natural killer cell function and disease progression in Portuguese patients with HIV - an immunogenetic perspective". 2010.
  32. Bettencourt, A; Silva, AM; Carvalho, C; Coutinho, E; Santos, E; Pereira, C; Mendonca, D; Costa, PP; Silva, BM. "Killer immunoglobulin-like receptor genes in Portuguese multiple sclerosis patients". 2010.
  33. Leal, B; Rangel, R; Carvalho, C; Moreira, L; Chaves, J; Silva, AM; Lima, JL; et al. "Inflammation in human mesial temporal lobe epilepsy with hippocampal sclerosis: a preliminary evaluation". 2010.
  34. Leal, B; Carvalho, C; Bettencourt, A; Leuschner, P; Nery, F; Carneiro, P; Cerveira, C; et al. "CCR5 and rheumatoid arthritis: is there an association?". 2010.
  35. Leal, B; Chaves, J; Carvalho, C; Bettencourt, A; Barros, M; Lopes, D; Silva, AM; et al. "MDR1 GENE POLYMORPHISMS AND DRUG-RESISTANT EPILEPSY IN A PORTUGUESE POPULATION". 2010.
  36. Martins Da Silva, AM; Lacerda, P; Guedes, L; Lopes, J; Leal, B; Pinho e Costa, PPE; Martins da Silva, BM. "VARIATION OF JME FAMILY PHENOTYPE ANTICIPATED BY PREVIOUS EEG CHARACTERIZATION: CLINICAL AND GENETIC EXPLORATION". 2009.
  37. Leal, B; Chaves, J; Carvalho, C; Bettencourt, A; Barros, M; Pereira, C; Costa, PP; et al. "Predictive genetic risk factors for febrile seizures and mesial temporal lobe epilepsy". 2009.
  38. Carvalho, C; Duarte, R; Pereira, C; Bettencourt, A; Quintas, Z; Vilar, M; Domingos, A; Costa, PP; Silva, BM. "Is susceptibility and protection to tuberculosis KIR dependent?". 2009.
  39. Rodrigues, P; Pereira, C; Bettencourt, A; Carvalho, C; Leal, B; Torres, T; Lobo, I; et al. "KIR genes and HLA-Cw*0602 in Portuguese patients with Psoriasis vulgaris". 2009.
  40. Leal, B; Pereira, C; Carvalho, C; Bettencourt, A; Costa, PP; Leuschner, P; Nery, F; et al. "HLA-DRB1 and rheumatoid arthritis: the anti-CCP antibodies effect". 2009.
  41. Bettencourt, A; Martins Silva, AM; Pereira, C; Coutinho, E; Santos, E; Carvalho, C; Mendonca, D; et al. "Killer cell immunoglobulin-like receptors (KIR) genes and multiple sclerosis: possible roles in protection and susceptibility". 2009.
  42. Chaves, J; Bettencourt, A; Leal, B; Carvalho, C; Pereira, C; Costa, PP; Monteiro, L; et al. "ApoE polymorphisms and susceptibility to mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) in a Portuguese population". 2008.
  43. Bettencourt, A; Silva, AM; Santos, E; Pereira, C; Carvalho, C; Leal, B; Costa, PP; Monteiro, L; Silva, BM. "Role of HFE in disease course and susceptibility in a group of Portuguese multiple sclerosis patients". 2008.
  44. Silva, A; Bettencourt, A; Santos, E; Coutinho, E; Pereira, C; Carvalho, C; Mendonca, D; et al. "No evidence of increased genetic susceptibility to autoimmune diseases in Portuguese Multiple Sclerosis patients". 2008.
  45. Bettencourt, A; Silva, A; Pereira, C; Coutinho, E; Santos, E; Carvalho, C; Mendonca, D; et al. "Benign course in multiple sclerosis: Association with autoimmunity and the protein tyrosine phosphatase (PTPN22) 1858C > T gene pollymorphism". 2008.
  46. Riedstra, S; Leite, G; Ferreira, C; Gomes, FB; Costa, PMP; Ferreira, JPM. "Optimization of the expression of single-chain antibodies using different Escherichia coli systems". 2007.
    10.1016/j.jbiotec.2007.07.457
  47. Pereira, C; Leal, B; Carvalho, C; Bettencourt, A; Machado, A; Casimiro, S; Silva, AM; et al. "Evidence for the presence of a common protective DRB1 allele for aid in the Portuguese population". 2007.
  48. Bettencourt, A; Pereira, C; Silva, AM; Carvalho, C; Leal, B; Couto, AR; Quintas, Z; et al. "HLA-DRB1*15-DQB1*06 haplotype and multiple sclerosis in Portuguese patients". 2007.
  49. Riedstra, S; Cerejo, L; Bras, S; Costa, PMP; Ferreira, JPM. "Optimization of the conditions for the expression of an anti-transthyretin scFv in Pichia pastoris". 2007.
    10.1016/j.biotec.2007.07.917
  50. Moreira, L; Lobato, L; Tavares, I; Matos, C; Carvalho, E; Pinheiro, J; Costa, PP. "Fibrinogen A alpha-chain Glu526V amyloidosis in seven Portuguese families". 2006.
  51. Fonseca, I; Lobato, L; Santos, J; Beirao, I; Cunha, C; Oliveira, JC; Cabrita, A; Costa, PP. "Vitamin D deficiency and serum levels of parathyroid hormone in Portuguese patients with familial amyloidotic polyneuropathy (FAP, TTR V30M)". 2006.
  52. Pereira, C; Chaves, J; Leal, B; Carvalho, A; Bettencourt, C; Costa, P; Monteiro, L; et al. "GABBR1 polymorphisms in portuguese mesial temporal lobe epilepsy patients". 2006.
  53. Bettencourt, A; Pereira, C; Silva, AM; Carvalho, C; Quintas, Z; Costa, PP; Monteiro, L. "Protective influence on Multiple Sclerosis by HLA-A*02: a study in the Portuguese population". 2006.
  54. Pereira, C; Silva, AM; Pinto, D; Bettencourt, A; Costa, PP; Koeleman, B; Silva, BM. "The role of PTPN22 1858T autoimmunity risk variant in Multiple Sclerosis Portuguese population". 2006.
  55. Silva, AM; Bettencourt, A; Pereira, C; Carvalho, C; Casimiro, S; Costa, PP; Monteiro, L; Silva, BM. "HLA-A*02 allele as a modulating factor in multiple sclerosis: Implications for susceptibility and severity". 2006.
  56. Pereira, C; Martins da Silva, A; Pinto, D; Bettencourt, A; Costa, P; Koeleman, B; Martins da Silva, B. "The role of PTPN22 1858T autoimmunity risk variant in a Portuguese multiple sclerosis population". 2006.
  57. Silva, AM; Pereira, C; Bettencourt, A; Carvalho, C; Casimiro, S; Quintas, Z; Costa, PP; Monteiro, L; Silva, BM. "Influence of HLA-DRB1 in clinical course and disease severity in Portuguese MS patients". 2005.
  58. Pereira, C; Silva, AM; Carvalho, C; Bettencourt, A; Casimiro, S; Quintas, Z; Costa, PM; Monteiro, L; Silva, BM. "TNFA promoter polymrphisms in Portuguese multiple sclerosis patients". 2005.
  59. Pereira, C; Pereira, O; Escada, R; Pinto, D; Selores, M; Carvalho, C; Costa, P; Massa, A; Silva, B. "HLA-CW*0602 and TNFa in psoriasis patients". 2005.
  60. Pereira, C; Silva, AM; Carvalho, C; Bettencourt, A; Casimiro, S; Quintas, Z; Costa, PM; Monteiro, L; Silva, BM. "DR/DQ antigens in papillary thyroid tumors". 2005.
  61. Carvalho, C; Pereira, C; Duarte, R; Casimiro, S; Quintas, Z; Costa, PP; Silva, BM. "Genetic susceptibility to tuberculosis: Association with HLA class II and TNA-a alleles". 2005.
  62. Silva, AM; Pereira, C; Bettencourt, A; Carvalho, C; Lacerda, P; Costa, PP; Monteiro, L; da Silva, BM. "Genetic susceptibility to multiple sclerosis in Portuguese patients: A study of HLA and non HLA genes". 2005.
  63. Pereira, C; Paulo, P; Costa, PPE; Barbot, C; Santos, M; Ramalheira, J; Lopes, J; et al. "Association studies with GABA[B]R1 polymorphisms and idiopathic generalised epilepsy in Portuguese patients". 2004.
  64. Paulo, P; Pereira, C; Carvalho, C; Costa, PP; Lima, J; Casimiro, S; Quintas, Z; Silva, AM; Martins, B. "GABA(B)R1 polymorphisms and idiopathic generalized epilepsy in Portuguese patients". 2004.

Outros

Outra produção
  1. The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker. 2022. Martins-Ferreira, R; Leal, BG; Costa, PP.
    10.3389/fncel.2022.852151
  2. Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M. 2008. Beirao, I; Lobato, L; Moreira, L; Costa, PM; Fonseca, I; Cabrita, A; Porto, G.
    10.1080/13506120802195840
  3. LIVER-TRANSPLANTATION FOR THE TREATMENT OF TYPE-I FAMILIAL AMYLOIDOTIC POLYNEUROPATHY. 1993. ANDREU, FRL; MUNARQUES, M; PARRILLA, P; SORIANO, JBE; COSTA, PP; COSTA, PMP; ALMEIDA, MR; et al.
Atividades

Orientação

Título / Tema
Papel desempenhado
Curso (Tipo)
Instituição / Organização
2019 - 2019 Epigenetic regulation of epilepsy-related signaling pathways in MTLE-HS and its impact on epileptogenesis
Orientador
Ciências Biomédicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013 - 2013 Inflammation and neurotransmission in mesial temporal lobe epilepsy
Coorientador
Ciências Biomédicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2011 - 2011 Genetic susceptibility and immune dysfunction in multiple sclerosis
Coorientador
Ciências Biomédicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2011 - 2011 Dissecting the role of amyloid fibril deposition in the kidney in familial amyloidotic polyneuropathy.
Orientador
Ciências Biomédicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2011 - 2011 Oculopatia na polineuropatia amiloidotica familiar tipo português.
Coorientador
Ciências Médicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2010 - 2010 Genetic characterization of the Innate Immune system of Lagomorphs (ILs, CCLs)
Coorientador
Patologia e Genética Molecular (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2003 - 2003 Envolvimento Renal na Génese da Anemia na Polineuropatia Amiloidótica Familiar Tipo Português
Coorientador
Ciências Médicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Membro de comissão

Descrição da atividade
Tipo de participação
Instituição / Organização
2010 - Atual Member of the Executive Committee of the National Newborn Screening Program.
Membro
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal